medigraphic.com
ISSN 1405-1710 (Print)

2024, Number 3

<< Back Next >>

Rev Cent Dermatol Pascua 2024; 33 (3)

Primary erythromelalgia

López-Cepeda LD, Zárate-Flores LM, Torres-Gordillo AA

Language: Spanish
References: 14
Page: 79-82
PDF size: 206.10 Kb.


ABSTRACT

Erythromelalgia is an underdiagnosed condition affecting mainly extremities. It is classified as primary or idiopathic if there is no underlying disease and is characterized by a burning sensation and erythema of the involved extremity. Symptoms appear when the limb is lowered or heat is applied, and improve with the application of cold or elevation of the limb. Diagnosis is clinical and treatment is symptomatic. The following article presents a case of a 16-year-old male with this pathology.


REFERENCES

  1. Jha SK, Karna B, Goodman MB. Erythromelalgia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available in: https://www.ncbi.nlm.nih.gov/books/NBK557787/

  2. Klein-Weigel PF, Volz TS, Richter JG. Erythromelalgia. Vasa. 2018; 47: 91-97.

  3. Leroux MB. Erythromelalgia: a cutaneous manifestation of neuropathy? An Bras Dermatol. 2018; 93: 86-94.

  4. Yang Y, Wang Y, Li S, Xu Z, Li H, Ma L et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet. 2004; 41: 171-174.

  5. Han C, Lampert A, Rush AM, Dib-Hajj SD, Wang X, Yang Y et al. Temperature dependence of erythromelalgia mutation L858F in sodium channel Nav1.7. Mol Pain. 2007; 3: 3.

  6. Drenth JP, Te Morsche RH, Mansour S, Mortimer PS. Primary erythermalgia as a sodium channelopathy: screening for SCN9A mutations: exclusion of a causal role of SCN10A and SCN11A. Arch Dermatol. 2008; 144: 320-324.

  7. Kondo T, Uehara T, Ikegami A, Ikusaka M. Paroxysmal burning pain caused by erythromelalgia. Lancet. 2014; 383: 1692.

  8. Parker LK, Ponte C, Howell KJ, Ong VH, Denton CP, Schreiber BE. Clinical features and management of erythromelalgia: long term follow-up of 46 cases. Clin Exp Rheumatol. 2017; 35: 80-84.

  9. Mann N, King T, Murphy R. Review of primary and secondary erythromelalgia. Clin Exp Dermatol. 2019; 44: 477-482.

  10. Thompson GH, Hahn G, Rang M. Erythromelalgia. Clin Orthop Relat Res. 1979; (144): 249-254.

  11. Sandroni P, Davis MD, Harper CM, Rogers RS 3rd, Harper CM Jr, Rogers RS 3rd et al. Neurophysiologic and vascular studies in erythromelalgia: a retrospective analysis. J Clin Neuromuscul Dis. 1999; 1: 57-63.

  12. Davis MD, O'Fallon WM, Rogers RS 3rd, Rooke TW. Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol. 2000; 136: 330-336.

  13. Leroux MB, Carbo E. Manejo racional de la eritromelalgia. Act Terap Dermatol. 2010; 33: 126-133.

  14. Dib-Hajj SD, Binshtok AM, Cummins TR, Jarvis MF, Samad T, Zimmermann K. Voltage-gated sodium channels in pain states: role in pathophysiology and targets for treatment. Brain Res Rev. 2009; 60: 65-83.




2020     |     www.medigraphic.com